American Journal of Ophthalmology
Volume 149, Issue 1 , Pages 4-6.e2, January 2010

When Should Anti-Vascular Endothelial Growth Factor Treatment Be Stopped in Age-Related Macular Degeneration?

  • Alain Gaudric

      Affiliations

    • Service d'Ophtalmologie, Hôpital Lariboisière, Assistance Publique–Hôpitaux de Paris and Université Paris 7 Diderot, Paris, France
    • Corresponding Author InformationInquiries to Alain Gaudric, MD, Service d'Ophtalmologie, Hôpital Lariboisière, 2 rue Ambroise Paré, 75010 Paris
    • ,
  • Salomon Y. Cohen

      Affiliations

    • Service d'Ophtalmologie, Hôpital Lariboisière, Assistance Publique–Hôpitaux de Paris and Université Paris 7 Diderot, Paris, France
    • Centre Ophtalmologique d'Imagerie et de Laser, Paris, France

Accepted 31 August 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0002-9394(09)00670-9

doi:10.1016/j.ajo.2009.08.039

American Journal of Ophthalmology
Volume 149, Issue 1 , Pages 4-6.e2, January 2010

Article Tools